Atlas FDA

ONX

6 FDA 510(k) clearances · Product code

289 daysmedian time to decision
375 days90th percentile
6clearances measured

FDA profile

Official device name
Ovarian Adnexal Mass Assessment Score Test System
Device class
Class II (moderate risk)
Regulation
21 CFR 866.6050
Medical specialty
Obstetrics/Gynecology
Flags
Third-party review eligible
FDA definition
An ovarian/adnexal mass assessment test is a devicem that measures one or more proteins in serum. It yields a single result for the likelihood that an adnexal pelvic mass in a woman, for whom surgery is planned, is malignant. The test isn for adjunctive use, in teh context of a negative primary clinical and radiological evaluation, to augmrent the identification of patienets whose gynecologic surgery requires oncology expertise and resources.
Sort:Newest firstOldest first

Export predicate table (CSV) Shareable report ◉ Watch exports: 3 free/month · reports & watching: free

RecordFirmDate
ROMA Calculation Tool Using Elecsys Assays (K153607)Roche Diagnostics2016-06-15
Lumipulse G ROMA (K160090)Fujirebio Diagnostics,Inc.2016-05-16
ARCHITECT ROMA (K151502)Fujirebio Diagnostics,Inc.2016-04-28
OVA1 Next Generation (K150588)Vermillion, Inc.2016-03-18
ROMA (HE4 EIA + ARCHITECT CA 125 II) (K103358)Fujirebio Diagnostics,Inc.2011-09-01
OVA1 TEST (DEN090004)Vermillion2009-09-11

Track ONX automatically

Every clearance here is in the API, with alerts when new ones post.